Where will the power come from? As AI workloads explode and U.S. data center power demand races toward 134 GW by 2030, the industry faces a fundamental constraint: the grid ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

Check the answer key for all sets of the CBSE Class 10 Social Science question paper 2025. The subject experts answered all questions, so it will be helpful to get an idea of your performance in the ...

ICSE Sample Papers 2026: The Council for the Indian School Certificate Examinations (CISCE) has released the ICSE Class 10 ...

The culinary community gathered for the first time in the city of Antigua, Guatemala for the unveiling of the 13th edition of ...

ECB's Rehn sees downside risks to inflation, urges action on Ukraine funding Inflation in the euro zone faces downside risks in the medium term, even as price growth has returned to the ECB's 2% ...

Many landlords fear that Section 24 could be applied to limited companies. This investigation explores Housing Associations, ...

Fresenius Kabi has launched its denosumab biosimilars Conexxence® and Bomyntra® across Europe following European Commission approval in July 2025 for all indications of their reference medicines ...